Trials / Conditions / Urothelial Cancer of Renal Pelvis
Urothelial Cancer of Renal Pelvis
6 registered clinical trials studyying Urothelial Cancer of Renal Pelvis — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metasta NCT06630247 | Exelixis | Phase 1 |
| Recruiting | uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto NCT05874921 | UroGen Pharma Ltd. | — |
| Not Yet Recruiting | Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma NCT05979909 | McMaster University | Phase 1 |
| Recruiting | Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma NCT04865939 | University of Texas Southwestern Medical Center | Phase 3 |
| Active Not Recruiting | Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer NCT04620603 | Case Comprehensive Cancer Center | Phase 1 |
| Available | Named Patient Program for Mitomycin for Pyelocalyceal Solution NCT05494411 | UroGen Pharma Ltd. | — |